Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 8,150,012 $ 10,574,292
Prepaid expenses and other current assets 256,468 54,537
Australia research and development incentives receivable 203,158 43,666
Total current assets 8,609,638 10,672,495
Deferred offering costs 1,147,216 651,582
Other assets 2,800 3,122
Total assets 9,759,654 11,327,199
Current liabilities:    
Accounts payable 1,041,626 960,401
Accrued expenses 2,055,940 1,185,595
Total current liabilities 3,097,566  
Total current liabilities and total liabilities 3,097,566 2,145,996
Commitments and contingencies
Stockholders' equity (deficit)    
Preferred stock, $0.0001 par value, 70,000,000 shares authorized, 0 shares issued and outstanding
Common stock, $0.0001 par value, 30,000,000 shares authorized, 8,416,032 and 7,584,980 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 842 758
Additional paid-in capital 41,823,112 37,618,438
Accumulated deficit (35,157,721) (28,437,993)
Accumulated other comprehensive income (loss) (4,145)  
Total stockholders' equity 6,662,088 9,181,203
Total liabilities and stockholders' equity $ 9,759,654 $ 11,327,199